About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,003 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,003 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1541-1560 of 13,003 trials

CompletedA Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsThe purpose of this study is to demonstrate that rivaroxaban is superior to placebo for reducing the risk of the primary composite outcome as defined by objectively confirmed…NCT02555878·Phoenix, Arizona and 150 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingComparison of Two Artificial Intelligence Scribe Products on Pediatric Subspecialty Provider Wellness and Experience, Patient Satisfaction, and Efficiency.The goal of this rapid, randomized quality improvement trial is to learn if implementing generative AI scribe software can enhance physician documentation efficiency and reduce…NCT07157943·Atlanta, Georgia

CompletedBehavioral Therapy to Treat Urinary Incontinence in Parkinson's DiseaseBackground: Parkinson's disease affects up to 3% of persons over the age of 65.NCT00866710·Atlanta, Georgia

CompletedGammagard Liquid and rHuPH20 in PIDThe purpose of the study is to develop a subcutaneous treatment option for participants with Primary Immunodeficiency Diseases (PID) that allows an administration of Immune…NCT00814320·Cypress, California and 13 others

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 580 others

CompletedA Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus InfectionThe primary objective is to assess the efficacy and safety of NPC-21 when administered prophylactically to cytomegalovirus (CMV) seronegative patients receiving a first kidney…NCT04225923·Phoenix, Arizona and 27 others

TerminatedCardiovalve Transfemoral Mitral Valve SystemThis study is to evaluate the safety and technical performance of the Cardiovalve Transfemoral Mitral Valve System with its associated procedure, to minimize mitral regurgitation.NCT03813524·Atlanta, Georgia and 1 other

CompletedA Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung CancerThe purpose of the study is to compare the overall response rate (ORR) in non-small cell lung cancer (NSCLC) participants treated with daratumumab in combination with atezolizumab…NCT03023423·Loma Linda, California and 46 others

TerminatedAddition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHNTo evaluate safety, immunogenicity and anti-tumor responses of intradermally delivered SNS-301 added to checkpoint inhibitor therapy in locally advanced unresectable or…NCT04034225·San Francisco, California and 9 others

CompletedLong-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenThis randomized multicenter phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual…NCT03271489·Birmingham, Alabama and 156 others

CompletedStudy In People With Type 2 DiabetesThis Phase 2 dose-ranging study will evaluate the efficacy, safety and tolerability of a range of doses of GW677954 compared with placebo over sixteen weeks of treatment in…NCT00196989·Birmingham, Alabama and 142 others

CompletedDyslipidemia of Obesity Intervention in TeensThis trial of pitavastatin will determine efficacy and safety in this high risk population and provide evidence for clinicians to target this treatable risk factor to achieve an…NCT02956590·Wilmington, Delaware and 15 others

CompletedA Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR MutationStudy to evaluate the efficacy of VX-661 in combination with ivacaftor (IVA, VX-770) through Week 12 in participants with cystic fibrosis (CF) who are heterozygous for the F508del…NCT02516410·Birmingham, Alabama and 40 others

CompletedImproving Primary Care in Patients With Mental DisordersThis study will determine the effectiveness of medical case management in improving the medical care of people with mental disorders or substance abuse problems.NCT00183313·Atlanta, Georgia and 1 other

Active not recruitingTesting the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialThis phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery.NCT04134260·Phoenix, Arizona and 349 others

CompletedA Safety Study of SGN-LIV1A in Breast Cancer PatientsThis study will examine the safety and tolerability of ladiratuzumab vedotin (LV) in patients with metastatic breast cancer.NCT01969643·Birmingham, Alabama and 37 others

CompletedThe Insulin-Only Bionic Pancreas Pivotal TrialThis multi-center randomized control trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas (BP) System versus…NCT04200313·Orange, California and 15 others

RecruitingThe Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyThe study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial.NCT05538208·San Francisco, California and 18 others

RecruitingA Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaThe purpose of the study is to evaluate glofitamab + gemcitabine + oxaliplatin in participants in the United States, including under-represented racial and ethnic populations…NCT06624085·La Jolla, California and 17 others

CompletedOpen-label Extension to Protocol 1042-0600To allow open-label extension to patients who have completed Protocol 1042-0600.NCT00512317·Birmingham, Alabama and 24 others

PreviousPage 78 of 651Next

in Atlanta

Heart Diseasein Atlanta